IP Library Granted Patent US 12,429,545
Granted Patent B2
US 12,429,545 · App. 18/530,136 · Granted Sep 30, 2025

MRI display output reflecting contrast agent concentration as a function of time

Inventors: Jiachao Liang (Palo Alto, CA); Jimmy R. Roehrig (Aptos, CA)
Assignee: Hologic, Inc.
G01R33/5601A61B5/055A61B5/742G01R33/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,429,545
App. No.
18/530,136
Granted
Sep 30, 2025
Kind
B2
Abstract

A magnetic resonant imaging (MRI) review workstation includes a control processor, and a display integrated or otherwise operatively coupled with the control processor, wherein the control processor is configured to receive and analyze magnetic resonant imaging information pertaining to an imaged volume of tissue, and to cause to be displayed on the display output information that reflects or is otherwise indicative of an absorption rate of a contrast agent in the volume of tissue.

Claims (25)

1. An image review workstation comprising:

a display;

at least one controller operatively coupled to the display; and

a memory coupled to the at least one controller, the memory storing instructions that, when executed by the at least one controller, performs a set of operations comprising:

receiving respective electronic magnetic resonant imaging (MRI) data of an imaged tissue volume acquired by different MRI scanners over respective periods of time after a respective contrast agent is introduced into a patient while at least a portion of the patient is positioned within respective different MRI scanners;

converting a plurality of signal enhancement ratio curves associated with the respective electronic MRI data from the different MRI scanners into an absorption rate curve, the absorption rate curve describing absorption rates of the respective contrast agent in the imaged tissue volume and compensating for a non-linear relationship between an MRI signal generated by an MRI scanner during imaging of the imaged tissue volume and a concentration of the respective contrast agent over time;

wherein the absorption rate curve is determined by deriving a signal intensity ratio for the imaged tissue volume based on an actual absorption rate of the respective contrast agent in the imaged tissue volume for all of the different MRI scanners;

normalizing the derived signal intensity ratio for the imaged tissue volume so that a signal enhancement ratio is independent of the different MRI scanners used to generate the electronic MRI data; and

displaying, on the display, the absorption rate curve of the respective contrast agent in the imaged tissue volume.

2. The image review workstation of claim 1 , wherein the respective electronic MRI data comprises first electronic MRI data acquired by a first MRI scanner, second electronic MRI data acquired by a second MRI scanner different from the first MRI scanner, and third electronic MRI data acquired by a third MRI scanner different from the first MRI scanner and the second MRI scanner, wherein the at least one controller receives the respective first, second, and third electronic MRI data from the respective first, second, and third MRI scanners.

3. The image review workstation of claim 1 , wherein the absorption rate curve is based at least in part upon a pre-contrast relaxation value of the imaged tissue volume as determined by the different MRI scanners.

4. The image review workstation of claim 3 , wherein the pre-contrast relaxation value of the imaged tissue volume is a value obtained using a reference tissue, wherein the reference tissue is pectoral muscle tissue or local fatty tissue, and the imaged tissue volume is a breast tissue.

5. The image review workstation of claim 3 , wherein the pre-contrast relaxation value of the imaged tissue volume is obtained by direct measurement prior to introduction of the respective contrast agent into the imaged tissue volume.

6. The image review workstation of claim 3 , wherein the pre-contrast relaxation value of the imaged tissue volume is based on a predetermined approximation.

7. The image review workstation of claim 1 , wherein the set of operations that the at least one controller performs further comprises displaying, on the display, an absolute value of absorption of the respective contrast agent in the imaged tissue volume.

8. The image review workstation of claim 1 , wherein the respective contrast agent is introduced into the patient by injection thereof into the patient's vasculature.

9. The image review workstation of claim 8 , wherein the respective electronic MRI data is acquired by a respective one of the different MRI scanners while the respective contrast agent travels through the patient's vasculature.

10. The image review workstation of claim 1 , wherein the absorption rate curve compensates for the non-linear relationship between the MRI signal and the concentration of the respective contrast agent over time caused by at least one operating parameter of the MRI scanner that generates the MRI signal.

11. The image review workstation of claim 10 , wherein the at least one operating parameter is at least one of repetition time (TR), echo time (TE), and flip angle of an alpha pulse.

12. The image review workstation of claim 1 , wherein the absorption rate curve provides an accurate indication of whether a wash out of the respective contrast agent has occurred in the imaged tissue volume during acquisition of the respective electronic MRI data by the different MRI scanners.

13. The image review workstation of claim 1 , wherein the respective electronic MRI data of the imaged volume of tissue acquired by the different MRI scanners corresponds to the signal enhancement ratio curves comprising a first signal enhancement ratio curve and a second signal enhancement ratio curve obtained for the same imaged tissue volume by the different MRI scanners, wherein the respective first and second signal enhancement curves are associated with respective Type I-III curves for the imaged tissue volume, a Type I curve indicating benign tissue, a Type II curve being suggestive of potential cancer, and a Type III curve being most indicative of cancer compared to the Type I curve and the Type II curve.

14. The image review workstation of claim 1 , the absorption rate curve includes the signal intensity ratio that is normalized to take into account the actual absorption rate of the respective contrast agent in the imaged tissue volume and that indicates whether a wash out of the respective contrast agent occurred in the imaged tissue volume during acquisition of the respective electronic MRI data.

15. The image review workstation of claim 1 , wherein the set of operations that the at least one controller performs further comprises generating the respective electronic MRI data by activation of at least one of the different MRI scanners.

16. The image review workstation of claim 1 , further comprising a plurality of MRI scanners.

17. The image review workstation of claim 1 , wherein the image review workstation is an MRI workstation.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 069172/0436 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC
Reel/Frame 075503/0086 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 14, 2024
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 069172/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: LIANG, JIACHAO; ROEHRIG, JIMMY R
To: HOLOGIC, INC.
Reel/Frame 065793/0003 →
Continuity (5)
Continuation 17734505 · May 2, 2022
Continuation 16534545 · Aug 7, 2019
Continuation 14384636
Provisional Application 61611877 · Mar 16, 2012
Related Publication 20240175955A1 · May 30, 2024
References Cited (22)
US 7693320B2 · Degani et al. · 2010 [cited by applicant]
US 7949164B2 · Degani et al. · 2011 [cited by applicant]
US 8175366B2 · Degani et al. · 2012 [cited by applicant]
US 11346910B2 · Liang · 2022 [cited by applicant]
US 11874356B2 · Liang · 2024 [cited by applicant]
US 20080125643A1 · Huisman et al. · 2008 [cited by applicant]
US 20100253342A1 · Kimura · 2010 [cited by applicant]
US 20110044524A1 · Wang et al. · 2011 [cited by applicant]
US 20150031983A1 · Liang · 2015 [cited by applicant]
Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, Griebel J. Microcirculation and Microvasculature in Breast Tumors: Pharmacokinetic Analysis of Dynamic MR Image Series. Magn Reson Med. 2004; 52(2):420-9. (10 … [cited by applicant]
Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991; 15(4):621-8. (26 pages). [cited by applicant]
C Kuhl, Radiology. 2007 244:356-378. The Current Status of Breast MR Imaging (23 pages). [cited by applicant]
CK Kuhl, PM Mielcareck, S Klaschnik, C Leutner, E Wardelmann, J Gieseke, H Schild, Radiology. 1999 211:101-110. Dynamic Breast MR Imaging: Are Signal Intensity Time Course Data Useful for Differential Diagnosis of Enhan… [cited by applicant]
Frahm J, Haase A, Matthaei D. Rapid three-dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr. 1986; 10(2):363-8. (6 pages). [cited by applicant]
Haacke EM, Tkach JA. Fast MR imaging: techniques and clinical applications. AJR Am J Roentgenol. 1990; 155(5):951-64. (14 pages). [cited by applicant]
Hoffman et al. “Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography” Magnetic Resonance in Medicine 33: 506-514 (1995). [cited by applicant]
Jansen, Shimauchi, Zak, Fan, Wood, Karczmar, Newstead. AJR2009; 193:832-839, Kinetic Curves of Malignant Lesions are Not Consistent Across MRI Systems: Need for Improved Standardization of Breast Dynamic Contrast-Enhanc… [cited by applicant]
PCT International Preliminary Report on Patentability in Application PCT/US2013/032681, mailed Sep. 24, 2015, 10 pages. [cited by applicant]
PCT International Search Report and Written Opinion for PCT/US13/32681, dated Jun. 17, 2013, Applicant Hologic, Inc., forms PCT/ISA/210, 220 and 237 (12 pages). [cited by applicant]
Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths. Invest Radiol. 2005; 40(11):715-24. (10 pages). [cited by applicant]
Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med. 2005; 54(3):507-12. (6 pages). [cited by applicant]
Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. MRM 1991; 17(2):357-67. (11 pages). [cited by applicant]